Page 162 - CW E-Magazine (1-4-2025)

News from Abroad

BIOLOGIC DRUG DELIVERY
Croda opens lipids manufacturing facility in US

Croda, UK-based supplier of
ingredients and speciality chemicals,
has opened a new lipids manufacturing
facility in Lamar, Pennsylvania, USA.

This facility represents a significant
step in Croda’s Pharma business stra-
tegy to ‘Empower biologics delivery’,
focussed on driving innovation in drug
delivery systems for next-generation
therapeutics.

The new 23,680 square foot, multi-
purpose facility will enhance Croda’s
capabilities in producing critical com-
ponents for drug delivery systems,
including lipids used for delivery of
nucleic acid-based therapeutics, mRNA
vaccines, gene editing therapies, and
novel cancer treatments.
duction of lipids that played a key ing critical public health initiatives,
Croda said the Lamar facility is role in the success of COVID-19 vaccines. including the scale up of lipids for the
the result of a collaboration with the delivery of mRNA COVID-19 vaccines
Administration for Strategic Prepared- The new facility complements Croda’s during the pandemic. The Lamar
ness and Response’s Biomedical Alabaster site in Alabama, formerly facility, part of a 37-acre multipurpose
Advanced Research and Development known as the Avanti Polar Lipids site, cGMP complex acquired in 2021, will
Authority (BARDA), and significantly and other locations outside of the support the local community creating
enhances the domestic manufacturing North American region, in Leek, UK, around 50 new jobs, spanning engi-
capacity in the USA for vital drug and Iksan, Korea. Together, these sites neering, administration, maintenance,
delivery systems – including the pro- build on Croda’s track record support- operations, and logistics.
SUSTAINABLE INGREDIENTS
Kao inks deal to source palm alternative from Future

Origins

Future Origins, a US-based joint Future Origins was formed and is leading global producer of surfactants,
venture that is commercialising sustain- majority-owned by Gevo, a US-based Kao has upheld rigorous standards for
able alternatives to critical ingredients in industrial biotechnology firm and both product quality and sustainability,
the formulations of cosmetics, personal backed by Unilever, Kao, and L’Oréal. especially in bioalcohols.”
care and cleaning products, announced
a multi-year purchase agreement with “Companies across the globe are According to the company, Nalo is
Japanese chemicals and cosmetics looking for ingredients made from the world’s first high-performing, drop-
firm, Kao Corporation, of its C12/C14 more resilient and traceable supply in replacement for widely used ingre-
fatty alcohol, sold under the Nalo brand chains and Future Origins has deve- dients traditionally made from palm oil.
name. The agreement is the largest loped Nalo to meet that need,” said John Nalo will be manufactured at industrial
Future Origins has entered for Nalo. Gugel, CEO of Future Origins. “As a scale in the US.

162 Chemical Weekly April 1, 2025

Contents Index to Advertisers Index to Products Advertised